GHRS Stock Analysis: Buy, Sell, or Hold?
GHRS - GH Research PLC Ordinary Shares
$20.64
-0.48 (-2.27%)
▼
5d:
+2.58%
30d:
-7.07%
90d:
+36.6%
BUY
HIGH Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Accumulation
None View Scanner →
Strength: 4.0/10
Get Alerted When GHRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GHRS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: GHRS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: GHRS is currently trading at $20.64, which is considered oversold relative to its 30-day fair value range of $20.72 to $23.33.
Technical Outlook: Technically, GHRS is in a strong uptrend. Immediate support is located at $19.74, while resistance sits at $25.94.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.50 (+87.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GHRS is in a strong uptrend. Immediate support is located at $19.74, while resistance sits at $25.94.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.50 (+87.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.72 -
$23.33
Company Quality Score
52/100
(HOLD)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 32th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 87.0% below Wall St target ($39.50)
Trading Range Analysis
30-Day Trading Range
$20.72 -
$23.33
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$3.56
(17.3%)
Support & Resistance Levels
Support Level
$19.74
Resistance Level
$25.94
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.57
Wall Street Target
$39.50
(+87.0%)
Share & Embed Analysis
Last updated: June 15, 2026 12:01 PM ET
Data refreshes hourly during market hours. Next update: 1:01 PM
Data refreshes hourly during market hours. Next update: 1:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GHRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 59 HOLD |
